Literature DB >> 6982750

Chronic lymphocytic leukemia. Immunologic markers and functional properties of the leukemic cells.

H J van der Reijden, R van der Gaag, J Pinkster, H C Rümke, M B van't Veer, C J Melief, A E von dem Borne.   

Abstract

In 230 cases of chronic lymphocytic leukemia (CLL), marker analysis was performed with rosette techniques and a panel of xeno-antisera. A monoclonal B-cell proliferation was found in the majority of cases (94%). In most cases, the B-cells carried IgM, with or without IgD. Cytoplasmic immunoglobulin-inclusion bodies were seen in 7% of the cases of B-CLL. The number of patients with non-B/non-T-CLL was small (2%) in this series. In eight patients (4%), a proliferation of T-cells was established. These patients had a different clinical presentation and marker analysis of the lymphocytes, together with functional studies, showed that this group represented a mixture of different disease processes. Functional analysis of the B-CLL cells in 19 cases showed a poor or absent mitogen response and in nine cases the absence of the capacity to differentiate in vitro into plasma cells and/or to produce immunoglobulins.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982750     DOI: 10.1002/1097-0142(19821215)50:12<2826::aid-cncr2820501223>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Identification of cellular immunoglobulins in chronic lymphocytic leukaemia by immunoperoxidase staining.

Authors:  G M Markey; R E McConnell; H D Alexander; T C Morris; J H Robertson
Journal:  J Clin Pathol       Date:  1983-12       Impact factor: 3.411

2.  "Well-differentiated" lymphocytic neoplasms. Immunologic findings correlated with clinical presentation and morphologic features.

Authors:  L J Medeiros; J G Strickler; L J Picker; A B Gelb; L M Weiss; R A Warnke
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

3.  Lymphoid proliferations in the orbit: malignant or benign?

Authors:  R van der Gaag; L Koornneef; P van Heerde; T M Vroom; J H Pegels; C A Feltkamp; H J Peeters; J P Gillissen; G M Bleeker; T E Feltkamp
Journal:  Br J Ophthalmol       Date:  1984-12       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.